Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
6.75
-0.36 (-5.06%)
Apr 30, 2026, 3:04 PM CST

SHE:002581 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
220.25506.4151.91183.8187.8
Trading Asset Securities
0.02----
Cash & Short-Term Investments
220.27506.4151.91183.8187.8
Cash Growth
-56.50%233.35%-17.35%-2.13%-33.91%
Accounts Receivable
279.6693.32172.62179.72272.96
Other Receivables
12.0552.2478.8718.3613.49
Receivables
291.72145.55251.49198.09286.45
Inventory
93.2579.6485.3180.0464.33
Other Current Assets
24.115.417.9956.4329.88
Total Current Assets
629.34747.01496.71518.36568.45
Property, Plant & Equipment
350.09274.74357.84705.47713.76
Long-Term Investments
938.341,0561,3551,5031,223
Other Intangible Assets
90.8193.47108.29126.32134.29
Long-Term Deferred Tax Assets
27.3211.216.1211.8425.28
Long-Term Deferred Charges
9.730.321.415.27.78
Other Long-Term Assets
122.7413.4412.260.4983.36
Total Assets
2,1682,1962,3372,8702,756
Accounts Payable
88.3935.3573.6943.6442.13
Accrued Expenses
13.3420.8322.519.3231.01
Short-Term Debt
32.532.7713.84150.42151.54
Current Portion of Long-Term Debt
17.72----
Current Portion of Leases
-0.17-13.4615.83
Current Income Taxes Payable
4.22-0.951.20.44
Current Unearned Revenue
2.9210.463.5926.863.43
Other Current Liabilities
31.6613.0319.03109.3814.17
Total Current Liabilities
190.7882.61133.61364.28258.54
Long-Term Debt
8.5----
Long-Term Leases
2.69-0.711.479.8
Long-Term Unearned Revenue
5.495.495.496.719.74
Long-Term Deferred Tax Liabilities
9.599.397.517.688.68
Other Long-Term Liabilities
4.9476.1216.099.67-
Total Liabilities
222173.61163.41389.82286.76
Common Stock
229.15229.15229.15229.15229.15
Additional Paid-In Capital
901.28866.41873.93858.5858.29
Retained Earnings
711.79828.08965.391,2981,301
Total Common Equity
1,8421,9242,0682,3852,388
Minority Interest
104.1698.67105.2694.9481.11
Shareholders' Equity
1,9462,0222,1742,4802,469
Total Liabilities & Equity
2,1682,1962,3372,8702,756
Total Debt
61.432.9414.55165.35177.16
Net Cash (Debt)
158.84503.47137.3618.4510.64
Net Cash Growth
-68.45%266.52%644.38%73.50%-90.91%
Net Cash Per Share
0.240.760.210.030.02
Filing Date Shares Outstanding
659.1659.74659.74659.74659.74
Total Common Shares Outstanding
659.1659.74659.74659.74659.74
Working Capital
438.56664.4363.1154.08309.91
Book Value Per Share
2.802.923.143.623.62
Tangible Book Value
1,7511,8301,9602,2592,254
Tangible Book Value Per Share
2.662.772.973.423.42
Buildings
-393.55486.08639.62612.92
Machinery
-431.4432.25413.16424.47
Construction In Progress
-38.1122.1791.4364.86
Source: S&P Global Market Intelligence. Standard template. Financial Sources.